AMAGEXIR Trademark

Trademark Overview

On Wednesday, July 16, 2008, a trademark application was filed for AMAGEXIR with the United States Patent and Trademark Office. The USPTO has given the AMAGEXIR trademark a serial number of 77523294. The federal status of this trademark filing is CANCELLED - SECTION 8 as of Friday, March 3, 2017. This trademark is owned by GlaxoSmithKline Biologicals S.A.. The AMAGEXIR trademark is filed in the Pharmaceutical Products category with the following description:

vaccines for human use
amagexir

General Information

Serial Number77523294
Word MarkAMAGEXIR
Filing DateWednesday, July 16, 2008
Status710 - CANCELLED - SECTION 8
Status DateFriday, March 3, 2017
Registration Number3823567
Registration DateTuesday, July 27, 2010
Mark Drawing4000 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateTuesday, May 11, 2010

Trademark Statements

Goods and Servicesvaccines for human use

Classification Information

International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes006, 018, 044, 046, 051, 052
Class Status Code2 - Sec. 8 - Entire Registration
Class Status DateFriday, March 3, 2017
Primary Code005
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History

Party NameGlaxoSmithKline Biologicals S.A.
Party Type30 - Original Registrant
Legal Entity Type03 - Corporation
AddressRixensart B-1330
BE
Party NameGlaxoSmithKline Biologicals S.A.
Party Type20 - Owner at Publication
Legal Entity Type03 - Corporation
AddressRixensart B-1330
BE
Party NameGlaxoSmithKline Biologicals S.A.
Party Type10 - Original Applicant
Legal Entity Type03 - Corporation
AddressRixensart B-1330
BE

Trademark Events

Event DateEvent Description
Friday, March 3, 2017CANCELLED SEC. 8 (6-YR)
Monday, July 27, 2015COURTESY REMINDER - SEC. 8 (6-YR) E-MAILED
Monday, June 8, 2015ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Monday, June 8, 2015TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Friday, March 15, 2013TEAS CHANGE OF CORRESPONDENCE RECEIVED
Wednesday, February 20, 2013ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Wednesday, February 20, 2013TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Tuesday, July 27, 2010REGISTERED-PRINCIPAL REGISTER
Thursday, May 13, 2010TEAS CHANGE OF CORRESPONDENCE RECEIVED
Tuesday, May 11, 2010OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Tuesday, May 11, 2010PUBLISHED FOR OPPOSITION
Wednesday, April 7, 2010LAW OFFICE PUBLICATION REVIEW COMPLETED
Tuesday, April 6, 2010APPROVED FOR PUB - PRINCIPAL REGISTER
Wednesday, March 31, 2010TEAS/EMAIL CORRESPONDENCE ENTERED
Wednesday, March 31, 2010CORRESPONDENCE RECEIVED IN LAW OFFICE
Wednesday, March 31, 2010TEAS RESPONSE TO SUSPENSION INQUIRY RECEIVED
Wednesday, October 21, 2009TEAS CHANGE OF CORRESPONDENCE RECEIVED
Tuesday, October 20, 2009NOTIFICATION OF LETTER OF SUSPENSION E-MAILED
Tuesday, October 20, 2009LETTER OF SUSPENSION E-MAILED
Tuesday, October 20, 2009SUSPENSION LETTER WRITTEN
Monday, October 19, 2009AMENDMENT FROM APPLICANT ENTERED
Monday, October 19, 2009CORRESPONDENCE RECEIVED IN LAW OFFICE
Monday, October 19, 2009FAX RECEIVED
Thursday, April 23, 2009NOTIFICATION OF INQUIRY AS TO SUSPENSION E-MAILED
Thursday, April 23, 2009INQUIRY TO SUSPENSION E-MAILED
Thursday, April 23, 2009SUSPENSION INQUIRY WRITTEN
Thursday, April 23, 2009LIE CHECKED SUSP - TO ATTY FOR ACTION
Thursday, April 23, 2009ASSIGNED TO LIE
Monday, April 6, 2009ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Monday, April 6, 2009TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Thursday, October 23, 2008NOTIFICATION OF LETTER OF SUSPENSION E-MAILED
Thursday, October 23, 2008LETTER OF SUSPENSION E-MAILED
Thursday, October 23, 2008SUSPENSION LETTER WRITTEN
Thursday, October 23, 2008ASSIGNED TO EXAMINER
Monday, July 21, 2008NEW APPLICATION ENTERED IN TRAM

Related Keywords

amagexir human vaccines